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Abstract Orphan symptoms are rarely assessed, particularly
at home. The aim of this multicenter prospective study was to
assess the prevalence of these symptoms and eventual factors
possibly associated in advanced cancer patients at admission
of a home care program. A prospective study was performed
at three home care programs in Italy. Patients' data were
collected, including age, sex, diagnosis, and Karnofsky status.
Possible contributing factors were analyzed; preexisting
neurological diseases, cerebral metastases, hyperthermia,
diabetes, a state of dehydration clinically evident and/or
oliguria, possible biochemical parameters when available,
data regarding recent chemotherapy, opioids and doses, use
of neuroleptics, benzodiazepine or anticonvulsants, cortico-
steroids, anti-inflammatory, and antibiotics were collected.
Myoclonus, hiccup, sweating, pruritus, and tenesmus, either
rectal or vesical, were assessed, according to a preliminary
definition, at time of home care program admission. Three
hundred sixty-two patients were surveyed at the three home
care programs. Globally, 48 patients presented one or more
orphan symptoms in the period taken into consideration,
and 7 patients presented more than 1 symptom. One patient
presented occasional and diffuse myoclonus. Nineteen patients
presented sweating, 13 patients presented pruritus, and 14
patients presented hiccup. Finally, nine patients presented
rectal or vesical tenesmus. There was a significant correlation
between sweating and transdermal fentanyl use (P=0.044),
fever (P=0.001), hiccup (P <0.0005), and vesical tenesmus
(P=0.028). Pruritus was not associated to any factor. Hiccup
was associated with gender (males, P=0.006) and sweating
(P <0.0005). Vesical tenesmus was associated with fever
(P=0.019) and sweating (P=0.028). Although the symptoms
examined have a low prevalence in advanced cancer patients
admitted to home care, the distress for patients may be high
and deserve further analyses. Given the low prevalence of
these symptoms, large studies are needed to find possible
associated factors.
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Introduction
Symptom assessment is of paramount importance to recog-
nize the priority of treatment in palliative care. The most
popular and validated tool for symptom assessment is the
Edmonton Symptom Assessment System [3, 13, 14]. Imple-
mentation of the ESAS provided improvements in symptom
screening, symptom control, and functional assessment [6].
However, there is a group of symptoms which is seldom
evaluated in most symptom assessment tools [5], and can be
considered as orphan symptoms. At the best of our knowl-
edge, no epidemiological or clinical study exists regarding the
prevalence of sweating, hiccup, myoclonus, pruritus, and
tenesmus in patients followed by a home palliative care team.
The Home Care–Italy group has been recently established
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with the intent to implement the information on cancer patients
followed at home, given the paucity of existing data in this
setting. The aim of this multicenter prospective study was to
assess the prevalence of these symptoms and eventual factors
possibly associated in advanced cancer patients at admission to
a home care program.
Patients and methods
A prospective study was performed at three home care pro-
grams in Italy. A consecutive sample of patients admitted to
home care programs in Turin (FARO foundation), L'Aquila
(L'Aquila per la vita), and Genua (ASL 6 genovese, Genua)
were surveyed for a period of 6 months. A preliminary inves-
tigation meeting by web was performed to homogenize the
definitions and the way to assess these symptoms, as well
as to identify simple factors possibly associated with these
symptoms (see Appendix). Informed consent and institu-
tional approval were obtained. Patients' data were collected,
including age, sex, diagnosis, and Karnofsky status. In a
preliminary consensus, it was decided, on the basis of
reliability and repeatability in the home setting, to explore
the following factors which potentially would have influence
the occurrence of orphan symptoms: preexisting neurological
diseases, cerebral metastases, hyperthermia, diabetes, a state
of dehydration clinically evident and/or oliguria, and possible
biochemical parameters when available. The choice was
based on the simplicity of data to be recorded at home and
available facilities. Moreover, data regarding recent chemo-
therapy, opioids and doses, use of neuroleptics, benzodiaze-
pine or anticonvulsants, corticosteroids, anti-inflammatory,
and antibiotics were collected.
Myoclonus, hiccup, sweating, pruritus, and tenesmus, either
rectal or vesical, were assessed at time of home care program
admission. Myoclonus was considered as a brief, involuntary
twitching of a muscle or a group of muscles. Characteristics
investigated were only nocturnal, occasionally, persistent
through the day, limited to few muscular groups, or diffused
[7, 8, 11]. Sweating was considered as the production of fluids
secreted by the sweat glands in the skin [2]. Characteristics
were nocturnal, persistent, relevant to need frequent dress
changes, and clearly consequential to drug administration.
Pruritus was considered as a sensation that causes the desire
or reflex to scratch and was assessed as localized, diffuse,
limited in time, persisting, associated with skin infection or
lesions, and allergy [16, 18]. Hiccup was defined as an invol-
untary contraction (myoclonic jerk) of the diaphragm that may
repeat several times per minute, involving a reflex arc. Once
triggered, the reflex causes a strong contraction of the dia-
phragm followed about 0.25 s later by closure of the vocal
cords, which results in the classic “hic” sound. Hiccups may
occur individually, or they may occur in bouts. The rhythm of
the hiccup, or the time between hiccups, tends to be relatively
constant. Hiccup was considered as occasional, persisting, or
continuous [12, 13]. Finally, tenesmus was considered as a
sensation of fullness or incomplete relief during urination or
defecation [14, 15].
Statistical analysis
Data were collected and analyzed by the SPSS Software 14.0
version (SPSS, Inc., Chicago, IL, USA). Descriptive summa-
ries for all measures are reported as means and standard
deviations (SD) for numeric variables, and as percentages
for categorical variables. Statistical analysis of quantitative
data, included descriptive statistics, was performed for all
the items. The chi-square test was used to make comparisons
with respect to categorical variables, and the Fisher exact test
was used if sample size criteria were not met for chi-square
approximation. The one-way analysis of variance was used
for parametric analysis. All P values were two-sided and
P values less than 0.05 were considered to indicate statistical
significance.
Results
Three hundred sixty-two patients were surveyed at the three
home care programs. Primary diagnoses were in a rank order
as follows: gastrointestinal 71, lung 54, genitourinary 54,
breast 36, liver 28, pancreas 22, hematological malignancies
16, head and neck 12, and others 69. The mean age was
73 years (SD 13.3), the mean Karnofsky at admission was
50.1 (SD 17.4), and 179 were males.
Globally, 48 patients presented one or more orphan symp-
toms in the period taken into consideration, and 7 patients
presented more than 1 symptom.
One patient presented occasional and diffuse myoclonus.
Nineteen patients presented sweating, 13 patients presented
pruritus, and 14 patients presented hiccup. Finally, nine pa-
tients presented rectal or vesical tenesmus. The characteristics
of these symptoms are reported in Table 1.
There was a significant correlation between sweating and
transdermal fentanyl use (P=0.044), fever (P=0.001), hiccup
(P <0.0005), and vesical tenesmus (P=0.028). Pruritus was
not associated to any factor taken into consideration. Hiccup
was associated with gender (males, P=0.006) and sweating
(P <0.0005). Vesical tenesmus was associated with fever
(P=0.019) and sweating (P=0.028).
Discussion
Literature regarding orphan symptoms, like myoclonus, sweat-
ing, pruritus, hiccup, as well as tenesmus, is scarce, and this is
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even more evident in patients followed at home by a palliative
care team. Furthermore, assessment tools have never been
assessed.
Myoclonus may develop in response to infection, head or
spinal cord injury, stroke, stress, brain tumors, kidney or liver
failure, lipid storage disease, chemical or drug poisoning, as a
side effect of certain drugs, particularly opioids and anticho-
linergics [6, 8, 16], or other disorders [8]. Sweating allows the
body to regulate its temperature. Sweating is controlled from a
center in the preoptic and anterior regions of the brain's
hypothalamus, where thermosensitive neurons are located
and may be influenced by several factors, humoral ones and
drugs for example [2]. Pruritus has been often caused by
infections, many medical and dermatologic disorders, allergy,
and some medications [9, 19]. Hiccup is caused by nerve
damage or irritation, from pre-phrenic nucleus irritation of
medulla, or other neurologic disorders [4, 10, 15, 17, 19].
Tenesmus is generally associated with several inflammatory
diseases of the bowel and urogenital system or pelvic floor
dysfunction [1].
These symptoms are not commonly reported in the most
popular and validated symptom assessment tools [3], and may
be considered as neglected symptoms. This is the first attempt
to assess the prevalence of these orphan symptoms which
have never been reported in advanced cancer patients
followed at home. These symptoms are really distressing
for patients and their families, and the symptom burden
has never been assessed.
As expected in this survey, a low prevalence of these
symptoms was observed at admission of a home care pro-
gram. The prevalence of myoclonus was 0.27 %, and, conse-
quently, no specific factor could be found to be associated
with that. The only patient presenting myoclonus was
receiving high doses of oxycodone (540 mg/day), haloperidol
5 mg/day, and prednisone 50 mg/day. It is likely that such a
symptom may occur in the terminal stage of disease or in
conjunction with high doses of opioids, but the number of
patients recruited was unexpectedly too small to evidence
positive findings. Sweating was more frequent, with 5.24 %
of patients presenting this symptom at admission. While the
association with fever was expected in some way, a cluster of
symptoms, such as hiccup and vesical tenesmus, was
unexplainable and may be due to other factors not taken into
account or a bias of the sample. Of interest, the presence of
sweating should contraindicate the use of transdermal fentanyl
which was found to be associated with sweating, due to its
unpredictable absorption in such circumstances. And 3.8 % of
patients presented hiccup which was more frequently ob-
served in males. This observation has never been reported
and provides important data in gender differences in the
presentation of hiccup. Pruritus was reported by 3.6 % of
patients admitted to home care, but no predictive factors were
found, including skin lesions or drugs. Vesical tenesmus was
associated with fever and sweating. This relationship deserves
further analysis in subsequent larger studies. Unfortunately,
comparative findings are unavailable, as no prospective sur-
vey has been reporting the prevalence of these symptoms.
The findings of this preliminary investigation show that a
minority of patients present the orphan symptoms examined.
While these symptoms have a low prevalence in advanced
cancer patients admitted to home care, the distress for patients
may be high and deserves further analyses to establish the
burden, in comparison with other concomitant symptoms,
limiting the quality of life. Given the low prevalence of these
symptoms, large studies are needed to find possible associated
factors.
According to these observations, this study has some limi-
tations, inherent to home care studies and the exploratory
nature of the study. A very simple dataset was chosen to
facilitate data collection which was partially missed, to provide
such preliminary information. Factors analyzed were based on
a previous consensus prevalently based on repeatability and
simplicity of data to be collected at home. It is likely that the
impact of these factors would be better assessed in an even
larger sample of patients. Thus, the findings of this survey
should be implemented in subsequent large studies. A lack of
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severity rating and influence on quality of life should be even-
tually assessed. The cross-sectional analysis at time of admis-
sion provides only point prevalence, and dynamics of these
symptoms should be explored in observational long-term
studies. Also, no specific treatment protocol was decided,
given the paucity of evidence regarding the treatment of
these symptoms in the advanced stage of disease. Thus, no
data on the efficacy of consequent treatment was recorded.
Data should be repeated a few days before dying to reflect the
switch of orphan symptom prevalence close to death [12].
In order to have a terminal cancer patient spending fulfill-
ing remaining of his life, the role of home care is important.
While difficult to perform, epidemiological and clinical re-
search at home may provide interesting data about the pattern
of orphan symptoms which are uncommonly reported in
symptom assessment tool, but may have an important burden
for patients and are worthwhile of consideration for a careful
monitoring and consequently an appropriate treatment. The
preliminary findings of this study should prompt large studies
to gather further information on these symptoms.
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